bimolane has been researched along with razoxane in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (48.39) | 18.7374 |
| 1990's | 10 (32.26) | 18.2507 |
| 2000's | 1 (3.23) | 29.6817 |
| 2010's | 4 (12.90) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Ma, GJ; Wang, S; Wang, YP; Xue, KX | 1 |
| Guo, Y; Lin, B; Lu, D; Xue, Y | 1 |
| Bale, G; Chesney, TM; Noah, PW; Rosenberg, EW; Skinner, RB; Xu, B | 1 |
| Chen, LJ; Liu, MZ; Wang, MY | 1 |
| He, SQ; Li, CF; Liu, TF; Zhen, XY; Zhou, J | 1 |
| Chen, YN; Fan, GC; Xia, SX; Zhang, YP | 1 |
| Dan, N; Zhang, TM | 1 |
| Li, GD; Liu, TX; Wang, MY; Zhang, TM | 1 |
| Otter, GM; Ren, YF; Schmid, FA | 1 |
| Creighton, AM; el-Hage, AN; Ferrans, VJ; Herman, EH; Witiak, DT | 1 |
| He, SQ; Kim, JH; Kim, SH | 1 |
| Fu, NW; Huang, KW; Ren, YF | 1 |
| Liu, TF; Zhang, XF; Zhang, ZY | 2 |
| Camerman, A; Camerman, N; Hempel, A | 1 |
| Finch, M; Hellmann, K; Hutchinson, GE; Li, XT; Pym, BA | 1 |
| Lin, C; Zhang, TM | 1 |
| Chen, ZY; Lin, C; Zhang, TM | 1 |
| Li, XF; Tu, ZH; Ye, H | 1 |
| Ma, GJ; Wu, JZ; Xue, KX | 1 |
| Gao, LS; Wang, XY; Zhang, MH | 1 |
| Hua, HY; Zhang, TM; Zhang, Y | 1 |
| Chen, SQ; Ma, GJ; Wu, JZ; Xue, KX | 1 |
| Guo, Y; Xie, X; Xue, Y | 1 |
| Eades, DM; Eastmond, DA; Frantz, CE; Grosovsky, AJ; Smith, H | 1 |
| Bian, S; Li, D; Mi, Y; Wang, J; Wang, Y; Xue, Y | 1 |
| Lu, DY; Lu, TR | 1 |
| Eastmond, DA; Roy, SK | 1 |
| Eastmond, DA; Hasegawa, LS; Vuong, MC | 1 |
| Gu, Y; Li, K; Zhang, J; Zhou, Y | 1 |
1 review(s) available for bimolane and razoxane
| Article | Year |
|---|---|
Antimetastatic activities and mechanisms of bisdioxopiperazine compounds.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Transformed; Fibrinogen; Humans; Mice; Molecular Targeted Therapy; Neoplasm Metastasis; Piperazines; Razoxane | 2010 |
1 trial(s) available for bimolane and razoxane
| Article | Year |
|---|---|
Preliminary report on AT1727 as a potential radiosensitizer.
Topics: Clinical Trials as Topic; Combined Modality Therapy; Humans; Lung Neoplasms; Neoplasms; Piperazines; Radiation-Sensitizing Agents; Random Allocation; Razoxane; Sarcoma; Soft Tissue Neoplasms | 1984 |
29 other study(ies) available for bimolane and razoxane
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
[Nuclear anomaly test in human lymphocytes in vitro].
Topics: Adult; Antineoplastic Agents; Cell Nucleus; Dose-Response Relationship, Drug; Female; Humans; Lymphocytes; Male; Micronucleus Tests; Mitomycin; Razoxane; Thiotepa | 1992 |
Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis.
Topics: Adolescent; Adult; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Psoriasis; Razoxane; Translocation, Genetic; Treatment Outcome | 1992 |
Efficacy of bimolane in the Malassezia ovalis model of psoriasis.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Betamethasone Valerate; Disease Models, Animal; Female; Injections, Intravenous; Malassezia; Methotrexate; Psoriasis; Rabbits; Razoxane; Skin | 1991 |
[Reproductive toxicity of bimolane in mice and rabbits].
Topics: Animals; Antineoplastic Agents; Embryonic and Fetal Development; Female; Fetal Death; Fetal Resorption; Mice; Piperazines; Pregnancy; Rabbits; Razoxane | 1989 |
Radiation survival properties of cultured human gastric adenocarcinoma cells and the effect of AT-1727.
Topics: Adenocarcinoma; Cell Survival; DNA Repair; Humans; In Vitro Techniques; Piperazines; Radiation-Sensitizing Agents; Razoxane; Stomach Neoplasms; Tumor Cells, Cultured | 1989 |
[Relationship between radiation sensitization and DNA damage by bimolane].
Topics: Animals; Antineoplastic Agents; Cross-Linking Reagents; DNA Damage; DNA, Neoplasm; Mice; Piperazines; Radiation-Sensitizing Agents; Razoxane; Sarcoma 180 | 1987 |
[Effects of bimolane on immune responses in mice].
Topics: Animals; Antineoplastic Agents; Female; Hemolytic Plaque Technique; Hypersensitivity, Delayed; Male; Mice; Piperazines; Razoxane; Rosette Formation | 1988 |
[Effects of bimolane and probimane on the incorporation of (3H)TdR, (3H)UR and (3H)Leu into Ehrlich ascites carcinoma cells iv vitro].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; DNA, Neoplasm; Female; Leucine; Male; Mice; Piperazines; Razoxane; RNA, Neoplasm; Thymidine; Tumor Cells, Cultured; Uridine | 1988 |
Further evaluation of bimolane and analogs as potential antitumor agents.
Topics: Animals; Drug Resistance; Female; Leukemia L1210; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Osteosarcoma; Piperazines; Razoxane; Sarcoma 180 | 1985 |
Comparison of the protective effect of ICRF-187 and structurally related analogues against acute daunorubicin toxicity in Syrian golden hamsters.
Topics: Animals; Body Weight; Cricetinae; Daunorubicin; Male; Mesocricetus; Piperazines; Razoxane; Stereoisomerism; Structure-Activity Relationship | 1985 |
Interaction of radiation and AT 1727 in HeLa S-3 cells in culture.
Topics: Antineoplastic Agents; Cell Survival; HeLa Cells; Humans; In Vitro Techniques; Piperazines; Razoxane | 1985 |
[Effects of bimolane on size, metastases and cyclic AMP levels of Lewis lung carcinoma].
Topics: Animals; Antineoplastic Agents; Cyclic AMP; Female; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Metastasis; Piperazines; Razoxane | 1984 |
Phase II evaluation of AT-1727 in advanced human cancer.
Topics: Antineoplastic Agents; Drug Evaluation; Humans; Neoplasms; Piperazines; Razoxane | 1983 |
Bimolane: structure determination indicates anticancer activity is attributable to ICRF-154.
Topics: Antineoplastic Agents; Models, Molecular; Piperazines; Razoxane; X-Ray Diffraction | 1984 |
Effect of AT1727 on growth and metastasis of murine tumours.
Topics: Animals; Antineoplastic Agents; Drug Administration Schedule; Female; Leukemia L1210; Lung Neoplasms; Lymphoma; Male; Melanoma; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Piperazines; Razoxane; Sarcoma 180 | 1983 |
[The cytokinetic effects of bimolane (AT-1727) on S180 cells].
Topics: Animals; Antineoplastic Agents; Cell Cycle; DNA, Neoplasm; Mice; Piperazines; Razoxane; Sarcoma 180 | 1982 |
[Pharmacological studies on bimolane (AT-1727), a new antineoplastic agent (author's transl)].
Topics: Animals; Antineoplastic Agents; Dogs; Immunity; Mice; Neoplasms, Experimental; Piperazines; Rats; Razoxane | 1980 |
[Leukemia associated with bimkolane].
Topics: Adolescent; Adult; Aged; Animals; Chromosome Aberrations; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mice; Micronucleus Tests; Middle Aged; Psoriasis; Razoxane; Retrospective Studies | 1994 |
[Effects of bimolane on cell cycle cytokinesis in human lymphocytes in vitro].
Topics: Adolescent; Adult; Antineoplastic Agents; Cell Cycle; Cell Division; Cells, Cultured; Female; Humans; Lymphocytes; Male; Micronucleus Tests; Mitosis; Razoxane | 1994 |
[140 cases of acute leukemia caused by bimolane].
Topics: Adult; Aged; Female; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Psoriasis; Razoxane; Retrospective Studies | 1993 |
Inhibitory effect of dioxopiperazine compounds on malondialdehyde formation induced by doxorubicin in rat liver mitochondria in vitro.
Topics: Animals; Antineoplastic Agents; Chlorides; Doxorubicin; Edetic Acid; Ferric Compounds; In Vitro Techniques; Male; Malondialdehyde; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Razoxane | 1993 |
[Mutagenic effects of bimolane].
Topics: Animals; Antineoplastic Agents; Chromosome Aberrations; Mice; Mutagenicity Tests; Mutagens; Razoxane | 1995 |
Translocation t(7;11)(P15;P15) in a patient with therapy-related acute myeloid leukemia following bimolane and ICRF-154 treatment for psoriasis.
Topics: Acute Disease; Adult; Antineoplastic Agents; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 7; Humans; Karyotyping; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Psoriasis; Razoxane; Translocation, Genetic | 1997 |
Bimolane: in vitro inhibitor of human topoisomerase II.
Topics: Antineoplastic Agents; DNA Topoisomerases, Type II; DNA, Kinetoplast; Enzyme Inhibitors; Humans; Mass Spectrometry; Razoxane; Substrate Specificity; Topoisomerase II Inhibitors | 1997 |
Acute leukemia association with psoriasis: a report on 100 patients from a single center in China.
Topics: Adult; Aged; China; Cohort Studies; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promyelocytic Leukemia Protein; Psoriasis; Radiation-Sensitizing Agents; Razoxane; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Transcription Factors; Tumor Suppressor Proteins; Young Adult | 2010 |
Bimolane induces multiple types of chromosomal aberrations in human lymphocytes in vitro.
Topics: Antineoplastic Agents; Cells, Cultured; Chromosome Aberrations; Humans; In Situ Hybridization, Fluorescence; Leukemia; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Mutagens; Neoplasms, Second Primary; Nondisjunction, Genetic; Polyploidy; Razoxane | 2011 |
A comparative study of the cytotoxic and genotoxic effects of ICRF-154 and bimolane, two catalytic inhibitors of topoisomerase II.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Chromosome Aberrations; Cytokinesis; Humans; Lymphocytes; Micronucleus Tests; Mutagenicity Tests; Mutagens; Razoxane; Topoisomerase II Inhibitors | 2013 |
Chronic myeloid leukaemia in a patient with psoriasis following bimolane treatment.
Topics: Antineoplastic Agents; Dermatologic Agents; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Psoriasis; Razoxane | 2020 |